For the financial period closing December 31 2024 ANIK decreased a loss per share of $-1.50 per share compare to $-4.29 a year ago and EPS improved from $-2.03 per share from the previous financial reporting period. The Revenue advanced by 7.334 % to $46.42 million from $43.25 million in the comparable financial reporting period a year ago and sequentially revenue improved by 20.76 % from $38.44 million. ANIKs' has clearly exceeded its industry peers on the revenue side, as the rest of the Medical Equipment and Supplies industry show 0.45% during the same period top-line rise thus far.
Focusing on the fourth quarter of 2024 the Medical Equipment and Supplies company reached balanced books at $0.00 per share, relative to the results of $-0.38 per share a year prior financial reporting period, In the previous financial reporting period the Nexalin Technology Inc realized $-0.23 per share.
The Medical Equipment and Supplies sector advisors start to scrutinize the second quarter of 2025 results. Now they observe operating loss of $-0.156593 million, from the Odyssey Health Inc , which has not stated any top-line so far, for the respective November to January 31 2025 reporting season.
For the October to December 31 2024 time-frame company decreased a loss per share of $-0.15 per share compare to $-0.19 a year ago and EPS improved from $-0.18 per share from the preceding reporting period. The revenue jumped by 43.151 % to $0.21 million from $0.15 million in the same reporting period a year ago and sequentially revenue advanced by 7.179 % from $0.20 million. Lyra Therapeutics Inc s' flourishes in the fourth quarter of 2024, while most of the corporations in the Medical Equipment and Supplies industries are experiencing challenges with the Receding businesses and experiencing diminishing revenue.
For the fourth quarter of 2024 earnings season BEAT slipped into deficit of $-0.18 per share compare to $0.04 a year before and earnings per share fell from $0.18 per share from the previous quarter. The revenue remained unchanged to $0.00 million from $112.03 million in the corresponding quarter a year before and sequentially from $114.66 million.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
4.07%